Abstract
Recent studies confirm that chronic low-grade inflammation is closely associated with metabolic syndromes, and anti-inflammatory therapy is a potential approach for treating cardiovascular diseases and type 2 diabetes. Accumulating evidence suggests that GPR120 activation is a feasible solution to ameliorating chronic inflammation and improving glucose metabolism. In this study we investigated whether ginsenoside Rb2 (Rb2), which exhibited regulatory activities in glucose and lipid metabolism, affected GPR120 expression in lipopolysaccharide (LPS)-activated mouse macrophage RAW264.7 cells, and examined the contribution of GPR120 activation to reducing the LPS-induced inflammatory response. LPS (100 ng/mL) activated the macrophages, resulting in dramatic increases in TNF-α, IL-6, IL-1β and NO production. Treatment with a ω-3 fatty acid α-linolenic acid (ALA, 50 μmol/L) produced moderate reduction in LPS-stimulated inflammatory cytokines and NO production (TNF-α and IL-6 were decreased by 46% and 42%, respectively). Pre-incubation with Rb2 (1 or 10 μmol/L) for 12 h before ALA treatment dramatically amplified the inhibitory effects of ALA (TNF-α and IL-6 were decreased by 74% and 86%, respectively). Compared to the treatment with ALA alone, pre-incubation with Rb2 resulted in a more prominent reduction in LPS-stimulated expression of iNOS and COX-2 and LPS-stimulated IKK/NF-κB phosphorylation and MAPK pathway activation. Rb2 (0.1–100 μmol/L) dose- and time-dependently increased both mRNA and protein expression of GPR120 in RAW264.7 cells, but treatment with Rb2 alone did not exert anti-inflammatory effect in LPS-activated RAW264.7 cells. In RAW264.7 cells transfected with GPR120 shRNA, the ameliorating effects of Rb2 on LPS-induced inflammation were abolished. In conclusion, Rb2 exerts anti-inflammatory effect in LPS-stimulated mouse macrophage RAW264.7 cells in vitro by increasing GPR120 expression and subsequently enhancing ω-3 fatty acid-induced GPR120 activation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Dilshara MG, Jayasooriya RG, Kang CH, Lee S, Park SR, Jeong JW, et al. Downregulation of pro-inflammatory mediators by a water extract of Schisandra chinensis (Turcz) Baill fruit in lipopolysaccharide-stimulated RAW 264.7 macrophage cells. Environ Toxicol Pharmacol 2013; 36: 256–64.
Gordon S . Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23–35.
Osborn O, Olefsky JM . The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012; 18: 363–74.
Lackey DE, Olefsky JM . Regulation of metabolism by the innate immune system. Nat Rev Endocrinol 2016; 12: 15–28.
Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005; 11: 90–4.
Iwasaki K, Harada N, Sasaki K, Yamane S, Iida K, Suzuki K, et al. Free fatty acid receptor GPR120 is highly expressed in enteroendocrine K cells of the upper small intestine and has a critical role in GIP secretion after fat ingestion. Endocrinology 2015; 156: 837–46.
Tanaka T, Katsuma S, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G . Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch Pharmacol 2008; 377: 523–7.
Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142: 687–98.
Raptis DA, Limani P, Jang JH, Ungethum U, Tschuor C, Graf R, et al. GPR120 on Kupffer cells mediates hepatoprotective effects of omega3-fatty acids. J Hepatol 2014; 60: 625–32.
Oh da Y, Walenta E, Akiyama TE, Lagakos WS, Lackey D, Pessentheiner AR, et al. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med 2014; 20: 942–7.
Choi KT . Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin 2008; 29: 1109–18.
Im DS, Nah SY . Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin. Acta Pharmacol Sin 2013; 34: 1367–73.
Fujimoto J, Sakaguchi H, Aoki I, Toyoki H, Khatun S, Tamaya T . Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur J Gynaecol Oncol 2001; 22: 339–41.
Yoon SJ, Park JY, Choi S, Lee JB, Jung H, Kim TD, et al. Ginsenoside Rg3 regulates S-nitrosylation of the NLRP3 inflammasome via suppression of iNOS. Biochem Biophys Res Commun 2015; 463: 1184–9.
Lee IA, Hyam SR, Jang SE, Han MJ, Kim DH . Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages. J Agric Food Chem 2012; 60: 9595–602.
Song Y, Zhao F, Zhang L, Du Y, Wang T, Fu F . Ginsenoside Rg1 exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vitro. Fitoterapia 2013; 91: 173–9.
Lee KT, Jung TW, Lee HJ, Kim SG, Shin YS, Whang WK . The antidiabetic effect of ginsenoside Rb2 via activation of AMPK. Arch Pharm Res 2011; 34: 1201–8.
Huang Q, Gao B, Jie Q, Wei BY, Fan J, Zhang HY, et al. Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis. Bone 2014; 66: 306–14.
Gao B, Huang Q, Jie Q, Zhang HY, Wang L, Guo YS, et al. Ginsenoside-Rb2 inhibits dexamethasone-induced apoptosis through promotion of GPR120 induction in bone marrow-derived mesenchymal stem cells. Stem Cells Dev 2015; 24: 781–90.
Wang T, Sun P, Chen L, Huang Q, Chen K, Jia Q, et al. Cinnamtannin D-1 protects pancreatic beta-cells from palmitic acid-induced apoptosis by attenuating oxidative stress. J Agric Food Chem 2014; 62: 5038–45.
Martinez FO, Sica A, Mantovani A, Locati M . Macrophage activation and polarization. Front Biosci 2008; 13: 453–61.
Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M . The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677–86.
Chen IT, Hsu PH, Hsu WC, Chen NJ, Tseng PH . Polyubiquitination of transforming growth factor beta-activated kinase 1 (TAK1) at lysine 562 residue regulates TLR4-mediated JNK and p38 MAPK activation. Sci Rep 2015; 5: 12300.
Hudson BD, Shimpukade B, Mackenzie AE, Butcher AJ, Pediani JD, Christiansen E, et al. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Mol Pharmacol 2013; 84: 710–25.
Kim N, Lee JO, Lee HJ, Kim HI, Kim JK, Lee YW, et al. Endogenous ligand for GPR120, docosahexaenoic acid, exerts benign metabolic effects on the skeletal muscles via AMP-activated protein kinase pathway. J Biol Chem 2015; 290: 20438–47.
Im DS . Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages. Eur J Pharmacol 2016; 785: 36–43.
Groeger AL, Cipollina C, Cole MP, Woodcock SR, Bonacci G, Rudolph TK, et al. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol 2010; 6: 433–41.
Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, et al. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int 2005; 67: 867–74.
Calder PC . Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 2015; 1851: 469–84.
Im DS . Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog Lipid Res 2012; 51: 232–7.
Mantovani A, Sica A, Locati M . Macrophage polarization comes of age. Immunity 2005; 23: 344–6.
Lee BC, Lee J . Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta 2014; 1842: 446–62.
Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116: 1494–505.
Ulven T, Christiansen E . Dietary fatty acids and their potential for controlling metabolic diseases through activation of FFA4/GPR120. Annu Rev Nutr 2015; 35: 239–63.
Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, et al. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci U S A 2006; 103: 15184–9.
Li X, Yu Y, Funk CD . Cyclooxygenase-2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4). FASEB J 2013; 27: 4987–97.
Acknowledgements
This work was supported by a grant from the National Natural Science Foundation (No 81473262, 81503124), the Science and Technology Commission of Shanghai Municipality Project (No 15431901000, 14ZR1447700) and Grant for Drug Discovery and Development, Chinese Academy of Sciences (No CASIMM0120162025, CASIMM0120164014).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary information is available at the website of Acta Pharmacologica Sinica.
Supplementary information
Rights and permissions
About this article
Cite this article
Huang, Q., Wang, T. & Wang, Hy. Ginsenoside Rb2 enhances the anti-inflammatory effect of ω-3 fatty acid in LPS-stimulated RAW264.7 macrophages by upregulating GPR120 expression. Acta Pharmacol Sin 38, 192–200 (2017). https://doi.org/10.1038/aps.2016.135
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2016.135
Keywords
This article is cited by
-
Ginsenoside Rg1 in neurological diseases: From bench to bedside
Acta Pharmacologica Sinica (2023)
-
Ginsenoside ameliorated ventilator-induced lung injury in rats
Journal of Intensive Care (2020)
-
Pharmacological activation of REV-ERBα represses LPS-induced microglial activation through the NF-κB pathway
Acta Pharmacologica Sinica (2019)
-
Emodin alleviates alternatively activated macrophage and asthmatic airway inflammation in a murine asthma model
Acta Pharmacologica Sinica (2018)
-
Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis
Acta Pharmacologica Sinica (2017)
